Ameritas Investment Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.89M | Buy |
21,203
+2,705
| +15% | +$332K | 0.08% | 265 |
|
|
2026
Q1 | $2.18M | Buy |
18,498
+3,791
| +26% | +$530K | 0.07% | 319 |
|
|
2025
Q4 | $2.41M | Sell |
14,707
-666
| -4% | -$104K | 0.07% | 282 |
|
|
2025
Q3 | $2.05M | Sell |
15,373
-732
| -5% | -$88.9K | 0.06% | 325 |
|
|
2025
Q2 | $2M | Buy |
16,105
+1,653
| +11% | +$210K | 0.06% | 336 |
|
|
2025
Q1 | $1.84M | Sell |
14,452
-181
| -1% | -$27.9K | 0.06% | 356 |
|
|
2024
Q4 | $2.11M | Sell |
14,633
-253
| -2% | -$36.3K | 0.07% | 301 |
|
|
2024
Q3 | $2.22M | Buy |
14,886
+3,833
| +35% | +$550K | 0.07% | 299 |
|
|
2024
Q2 | $1.39M | Sell |
11,053
-412
| -4% | -$64.6K | 0.05% | 472 |
|
|
2024
Q1 | $2.11M | Hold |
11,465
| – | – | 0.07% | 317 |
|
|
2023
Q4 | $2.06M | Sell |
11,465
-164
| -1% | -$25.5K | 0.08% | 296 |
|
|
2023
Q3 | $1.85M | Sell |
11,629
-1,302
| -10% | -$213K | 0.07% | 287 |
|
|
2023
Q2 | $1.83M | Sell |
12,931
-215
| -2% | -$34.5K | 0.07% | 320 |
|
|
2023
Q1 | $2.21M | Sell |
13,146
-218
| -2% | -$38.9K | 0.09% | 255 |
|
|
2022
Q4 | $2.55M | Buy |
13,364
+92
| +0.7% | +$16.7K | 0.1% | 209 |
|
|
2022
Q3 | $2.48M | Sell |
13,272
-476
| -3% | -$100K | 0.11% | 169 |
|
|
2022
Q2 | $2.23M | Hold |
13,748
| – | – | 0.1% | 212 |
|
|
2022
Q1 | $2.59M | Hold |
13,748
| – | – | 0.09% | 230 |
|
|
2021
Q4 | $3.64M | Buy |
13,748
+204
| +2% | +$55K | 0.12% | 155 |
|
|
2021
Q3 | $3.91M | Sell |
13,544
-257
| -2% | -$65.9K | 0.14% | 112 |
|
|
2021
Q2 | $2.75M | Sell |
13,801
-219
| -2% | -$42.5K | 0.1% | 208 |
|
|
2021
Q1 | $2.73M | Buy |
14,020
+110
| +0.8% | +$22.6K | 0.1% | 203 |
|
|
2020
Q4 | $2.67M | Buy |
13,910
+87
| +0.6% | +$15.8K | 0.12% | 186 |
|
|
2020
Q3 | $2.04M | Buy |
13,823
+204
| +1% | +$29.2K | 0.09% | 225 |
|
|
2020
Q2 | $1.68M | Sell |
13,619
-4,045
| -23% | -$476K | 0.08% | 260 |
|
|
2020
Q1 | $1.71M | Buy |
17,664
+28
| +0.2% | +$2.7K | 0.1% | 211 |
|
|
2019
Q4 | $1.63M | Buy |
17,636
+219
| +1% | +$18.4K | 0.07% | 312 |
|
|
2019
Q3 | $1.34M | Buy |
17,417
+13,362
| +330% | +$1.17M | 0.06% | 387 |
|
|
2019
Q2 | $349K | Buy |
4,055
+855
| +27% | +$58.3K | 0.02% | 833 |
|
|
2019
Q1 | $189K | Hold |
3,200
| – | – | 0.01% | 1081 |
|
|
2018
Q4 | $169K | Hold |
3,200
| – | – | 0.01% | 1057 |
|
|
2018
Q3 | $177K | Hold |
3,200
| – | – | 0.01% | 1165 |
|
|
2018
Q2 | $151K | Hold |
3,200
| – | – | 0.01% | 1254 |
|
|
2018
Q1 | $116K | Hold |
3,200
| – | – | 0.01% | 1408 |
|
|
2017
Q4 | $116K | Buy |
3,200
+284
| +10% | +$10.3K | 0.01% | 1421 |
|
|
2017
Q3 | $127K | Hold |
2,916
| – | – | 0.01% | 1314 |
|
|
2017
Q2 | $121K | Hold |
2,916
| – | – | 0.01% | 1351 |
|
|
2017
Q1 | $103K | Buy |
+2,916
| New | +$92.3K | 0.01% | 1416 |
|
Other funds holding RGEN
UCFA
MC
WA
Ameritas Investment Partners's RGEN Position: Q2 2026 in Review
Ameritas Investment Partners increased its Repligen (RGEN) stake by 15% in Q2 2026, buying an estimated $332K and bringing the position to 21,203 shares worth $2.89M. The position accounts for 0.08% of the portfolio, ranked #265.
Ameritas Investment Partners first reported a position in RGEN in Q1 2017 and has held it in 38 quarters since. The position peaked at $3.91M in Q3 2021. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Ameritas Investment Partners held 21,203 shares of Repligen worth $2.89M as of Q2 2026.
- Ameritas Investment Partners bought 2,705 Repligen shares in Q2 2026, an estimated $332K.
- Repligen made up 0.08% of Ameritas Investment Partners's portfolio in Q2 2026, its #265 holding.
- Ameritas Investment Partners first reported a position in Repligen in Q1 2017 and has held it in 38 quarters since.
- Ameritas Investment Partners's Repligen position peaked at $3.91M in Q3 2021.
- 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.